Global Checkpoint Inhibitors for Treating Cancer Market Data Survey Report 2015-2025
SUMMARY
Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.
The global Checkpoint Inhibitors for Treating Cancer market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025.
The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major End-Use
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.
The global Checkpoint Inhibitors for Treating Cancer market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025.
The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major End-Use
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
- Bristol-Myers Squibb(BMS)
- Merck
- Roche
- Melanoma treatment
- Bladder cancer treatment
- Others
- PD-1 inhibitors
- PD-L1 inhibitors
- CTLA-4 inhibitors
- Asia-Pacific
- North America
- Europe
- South America
- Middle East & Africa
1 GLOBAL MARKET OVERVIEW
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of End-Use
1.1.4 Scope of Product Type
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
Fig Global Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2015-2019 (Million USD)
Fig Global Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2015-2019 (Volume)
Fig Global Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2020-2025 (Million USD)
Fig Global Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2020-2025 (Volume)
2 REGIONAL MARKET
2.1 Regional Sales
Tab Regional Sales Revenue 2015-2019 (Million USD)
Tab Regional Sales Volume 2015-2019 (Volume)
2.2 Regional Demand
Tab Regional Demand and CAGR List 2015-2019 (Million USD)
Tab Regional Demand and CAGR List 2015-2019 (Volume)
Tab Regional Demand Forecast and CAGR 2020-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2020-2025 (Volume)
2.3 Regional Trade
Tab Regional Export 2015-2019 (Million USD)
Tab Regional Export 2015-2019 (Volume)
Tab Regional Import 2015-2019 (Million USD)
Tab Regional Import 2015-2019 (Volume)
3 KEY MANUFACTURERS
3.1 Bristol-Myers Squibb(BMS)
3.1.1 Company Information
Tab Company Profile List of Bristol-Myers Squibb(BMS)
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Bristol-Myers Squibb(BMS)
3.1.4 Recent Development
3.2 Merck
3.2.1 Company Information
Tab Company Profile List of Merck
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Merck
3.3 Roche
3.3.1 Company Information
Tab Company Profile List of Roche
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Roche
4 MAJOR END-USE
4.1 Melanoma treatment
4.1.1 Overview
Tab Summary of Consumption Distribution of Melanoma treatment
4.1.2 Melanoma treatment Market Size and Forecast
Fig Melanoma treatment Market Size and CAGR 2015-2019 (Million USD)
Fig Melanoma treatment Market Size and CAGR 2015-2019 (Volume)
Fig Melanoma treatment Market Forecast and CAGR 2020-2025 (Million USD)
Fig Melanoma treatment Market Forecast and CAGR 2020-2025 (Volume)
4.2 Bladder cancer treatment
4.2.1 Overview
Tab Summary of Consumption Distribution of Bladder cancer treatment
4.2.2 Bladder cancer treatment Market Size and Forecast
Fig Bladder cancer treatment Market Size and CAGR 2015-2019 (Million USD)
Fig Bladder cancer treatment Market Size and CAGR 2015-2019 (Volume)
Fig Bladder cancer treatment Market Forecast and CAGR 2020-2025 (Million USD)
Fig Bladder cancer treatment Market Forecast and CAGR 2020-2025 (Volume)
4.3 Others
4.3.1 Overview
Tab Summary of Consumption Distribution of Others
4.3.2 Others Market Size and Forecast
Fig Others Market Size and CAGR 2015-2019 (Million USD)
Fig Others Market Size and CAGR 2015-2019 (Volume)
Fig Others Market Forecast and CAGR 2020-2025 (Million USD)
Fig Others Market Forecast and CAGR 2020-2025 (Volume)
5 MARKET BY TYPE
5.1 PD-1 inhibitors
5.1.1 Overview
Tab Product Overview of PD-1 inhibitors
5.1.2 PD-1 inhibitors Market Size and Forecast
Fig PD-1 inhibitors Market Size and CAGR 2015-2019 (Million USD)
Fig PD-1 inhibitors Market Size and CAGR 2015-2019 (Volume)
Fig PD-1 inhibitors Market Forecast and CAGR 2020-2025 (Million USD)
Fig PD-1 inhibitors Market Forecast and CAGR 2020-2025 (Volume)
5.2 PD-L1 inhibitors
5.2.1 Overview
Tab Product Overview of PD-L1 inhibitors
5.2.2 PD-L1 inhibitors Market Size and Forecast
Fig PD-L1 inhibitors Market Size and CAGR 2015-2019 (Million USD)
Fig PD-L1 inhibitors Market Size and CAGR 2015-2019 (Volume)
Fig PD-L1 inhibitors Market Forecast and CAGR 2020-2025 (Million USD)
Fig PD-L1 inhibitors Market Forecast and CAGR 2020-2025 (Volume)
5.3 CTLA-4 inhibitors
5.3.1 Overview
Tab Product Overview of CTLA-4 inhibitors
5.3.2 CTLA-4 inhibitors Market Size and Forecast
Fig CTLA-4 inhibitors Market Size and CAGR 2015-2019 (Million USD)
Fig CTLA-4 inhibitors Market Size and CAGR 2015-2019 (Volume)
Fig CTLA-4 inhibitors Market Forecast and CAGR 2020-2025 (Million USD)
Fig CTLA-4 inhibitors Market Forecast and CAGR 2020-2025 (Volume)
6 PRICE OVERVIEW
6.1 Price by Manufacturers
Tab Different Products Prices List of Major Manufacturers
6.2 Price by End-Use
Tab Different Products Prices List of End-Use
6.3 Price by Type
Tab Different Products Prices List of Produt Type
7 CONCLUSION
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of End-Use
1.1.4 Scope of Product Type
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
Fig Global Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2015-2019 (Million USD)
Fig Global Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2015-2019 (Volume)
Fig Global Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2020-2025 (Million USD)
Fig Global Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2020-2025 (Volume)
2 REGIONAL MARKET
2.1 Regional Sales
Tab Regional Sales Revenue 2015-2019 (Million USD)
Tab Regional Sales Volume 2015-2019 (Volume)
2.2 Regional Demand
Tab Regional Demand and CAGR List 2015-2019 (Million USD)
Tab Regional Demand and CAGR List 2015-2019 (Volume)
Tab Regional Demand Forecast and CAGR 2020-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2020-2025 (Volume)
2.3 Regional Trade
Tab Regional Export 2015-2019 (Million USD)
Tab Regional Export 2015-2019 (Volume)
Tab Regional Import 2015-2019 (Million USD)
Tab Regional Import 2015-2019 (Volume)
3 KEY MANUFACTURERS
3.1 Bristol-Myers Squibb(BMS)
3.1.1 Company Information
Tab Company Profile List of Bristol-Myers Squibb(BMS)
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Bristol-Myers Squibb(BMS)
3.1.4 Recent Development
3.2 Merck
3.2.1 Company Information
Tab Company Profile List of Merck
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Merck
3.3 Roche
3.3.1 Company Information
Tab Company Profile List of Roche
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Roche
4 MAJOR END-USE
4.1 Melanoma treatment
4.1.1 Overview
Tab Summary of Consumption Distribution of Melanoma treatment
4.1.2 Melanoma treatment Market Size and Forecast
Fig Melanoma treatment Market Size and CAGR 2015-2019 (Million USD)
Fig Melanoma treatment Market Size and CAGR 2015-2019 (Volume)
Fig Melanoma treatment Market Forecast and CAGR 2020-2025 (Million USD)
Fig Melanoma treatment Market Forecast and CAGR 2020-2025 (Volume)
4.2 Bladder cancer treatment
4.2.1 Overview
Tab Summary of Consumption Distribution of Bladder cancer treatment
4.2.2 Bladder cancer treatment Market Size and Forecast
Fig Bladder cancer treatment Market Size and CAGR 2015-2019 (Million USD)
Fig Bladder cancer treatment Market Size and CAGR 2015-2019 (Volume)
Fig Bladder cancer treatment Market Forecast and CAGR 2020-2025 (Million USD)
Fig Bladder cancer treatment Market Forecast and CAGR 2020-2025 (Volume)
4.3 Others
4.3.1 Overview
Tab Summary of Consumption Distribution of Others
4.3.2 Others Market Size and Forecast
Fig Others Market Size and CAGR 2015-2019 (Million USD)
Fig Others Market Size and CAGR 2015-2019 (Volume)
Fig Others Market Forecast and CAGR 2020-2025 (Million USD)
Fig Others Market Forecast and CAGR 2020-2025 (Volume)
5 MARKET BY TYPE
5.1 PD-1 inhibitors
5.1.1 Overview
Tab Product Overview of PD-1 inhibitors
5.1.2 PD-1 inhibitors Market Size and Forecast
Fig PD-1 inhibitors Market Size and CAGR 2015-2019 (Million USD)
Fig PD-1 inhibitors Market Size and CAGR 2015-2019 (Volume)
Fig PD-1 inhibitors Market Forecast and CAGR 2020-2025 (Million USD)
Fig PD-1 inhibitors Market Forecast and CAGR 2020-2025 (Volume)
5.2 PD-L1 inhibitors
5.2.1 Overview
Tab Product Overview of PD-L1 inhibitors
5.2.2 PD-L1 inhibitors Market Size and Forecast
Fig PD-L1 inhibitors Market Size and CAGR 2015-2019 (Million USD)
Fig PD-L1 inhibitors Market Size and CAGR 2015-2019 (Volume)
Fig PD-L1 inhibitors Market Forecast and CAGR 2020-2025 (Million USD)
Fig PD-L1 inhibitors Market Forecast and CAGR 2020-2025 (Volume)
5.3 CTLA-4 inhibitors
5.3.1 Overview
Tab Product Overview of CTLA-4 inhibitors
5.3.2 CTLA-4 inhibitors Market Size and Forecast
Fig CTLA-4 inhibitors Market Size and CAGR 2015-2019 (Million USD)
Fig CTLA-4 inhibitors Market Size and CAGR 2015-2019 (Volume)
Fig CTLA-4 inhibitors Market Forecast and CAGR 2020-2025 (Million USD)
Fig CTLA-4 inhibitors Market Forecast and CAGR 2020-2025 (Volume)
6 PRICE OVERVIEW
6.1 Price by Manufacturers
Tab Different Products Prices List of Major Manufacturers
6.2 Price by End-Use
Tab Different Products Prices List of End-Use
6.3 Price by Type
Tab Different Products Prices List of Produt Type
7 CONCLUSION
LIST OF TABLES
Tab Regional Sales Revenue 2015-2019 (Million USD)
Tab Regional Sales Volume 2015-2019 (Volume)
Tab Regional Demand and CAGR List 2015-2019 (Million USD)
Tab Regional Demand and CAGR List 2015-2019 (Volume)
Tab Regional Demand Forecast and CAGR 2020-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2020-2025 (Volume)
Tab Regional Export 2015-2019 (Million USD)
Tab Regional Export 2015-2019 (Volume)
Tab Regional Import 2015-2019 (Million USD)
Tab Regional Import 2015-2019 (Volume)
Tab Company Profile List of Bristol-Myers Squibb(BMS)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Bristol-Myers Squibb(BMS)
Tab Company Profile List of Merck
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Merck
Tab Company Profile List of Roche
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Roche
Tab Summary of Consumption Distribution of Melanoma treatment
Tab Summary of Consumption Distribution of Bladder cancer treatment
Tab Summary of Consumption Distribution of Others
Tab Product Overview of PD-1 inhibitors
Tab Product Overview of PD-L1 inhibitors
Tab Product Overview of CTLA-4 inhibitors
Tab Different Products Prices List of Major Manufacturers
Tab Different Products Prices List of End-Use
Tab Different Products Prices List of Produt Type
Tab Regional Sales Revenue 2015-2019 (Million USD)
Tab Regional Sales Volume 2015-2019 (Volume)
Tab Regional Demand and CAGR List 2015-2019 (Million USD)
Tab Regional Demand and CAGR List 2015-2019 (Volume)
Tab Regional Demand Forecast and CAGR 2020-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2020-2025 (Volume)
Tab Regional Export 2015-2019 (Million USD)
Tab Regional Export 2015-2019 (Volume)
Tab Regional Import 2015-2019 (Million USD)
Tab Regional Import 2015-2019 (Volume)
Tab Company Profile List of Bristol-Myers Squibb(BMS)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Bristol-Myers Squibb(BMS)
Tab Company Profile List of Merck
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Merck
Tab Company Profile List of Roche
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Roche
Tab Summary of Consumption Distribution of Melanoma treatment
Tab Summary of Consumption Distribution of Bladder cancer treatment
Tab Summary of Consumption Distribution of Others
Tab Product Overview of PD-1 inhibitors
Tab Product Overview of PD-L1 inhibitors
Tab Product Overview of CTLA-4 inhibitors
Tab Different Products Prices List of Major Manufacturers
Tab Different Products Prices List of End-Use
Tab Different Products Prices List of Produt Type
LIST OF FIGURES
Fig Global Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2015-2019 (Million USD)
Fig Global Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2015-2019 (Volume)
Fig Global Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2020-2025 (Million USD)
Fig Global Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2020-2025 (Volume)
Fig Melanoma treatment Market Size and CAGR 2015-2019 (Million USD)
Fig Melanoma treatment Market Size and CAGR 2015-2019 (Volume)
Fig Melanoma treatment Market Forecast and CAGR 2020-2025 (Million USD)
Fig Melanoma treatment Market Forecast and CAGR 2020-2025 (Volume)
Fig Bladder cancer treatment Market Size and CAGR 2015-2019 (Million USD)
Fig Bladder cancer treatment Market Size and CAGR 2015-2019 (Volume)
Fig Bladder cancer treatment Market Forecast and CAGR 2020-2025 (Million USD)
Fig Bladder cancer treatment Market Forecast and CAGR 2020-2025 (Volume)
Fig Others Market Size and CAGR 2015-2019 (Million USD)
Fig Others Market Size and CAGR 2015-2019 (Volume)
Fig Others Market Forecast and CAGR 2020-2025 (Million USD)
Fig Others Market Forecast and CAGR 2020-2025 (Volume)
Fig PD-1 inhibitors Market Size and CAGR 2015-2019 (Million USD)
Fig PD-1 inhibitors Market Size and CAGR 2015-2019 (Volume)
Fig PD-1 inhibitors Market Forecast and CAGR 2020-2025 (Million USD)
Fig PD-1 inhibitors Market Forecast and CAGR 2020-2025 (Volume)
Fig PD-L1 inhibitors Market Size and CAGR 2015-2019 (Million USD)
Fig PD-L1 inhibitors Market Size and CAGR 2015-2019 (Volume)
Fig PD-L1 inhibitors Market Forecast and CAGR 2020-2025 (Million USD)
Fig PD-L1 inhibitors Market Forecast and CAGR 2020-2025 (Volume)
Fig CTLA-4 inhibitors Market Size and CAGR 2015-2019 (Million USD)
Fig CTLA-4 inhibitors Market Size and CAGR 2015-2019 (Volume)
Fig CTLA-4 inhibitors Market Forecast and CAGR 2020-2025 (Million USD)
Fig CTLA-4 inhibitors Market Forecast and CAGR 2020-2025 (Volume)
Fig Global Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2015-2019 (Million USD)
Fig Global Checkpoint Inhibitors for Treating Cancer Market Size and CAGR 2015-2019 (Volume)
Fig Global Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2020-2025 (Million USD)
Fig Global Checkpoint Inhibitors for Treating Cancer Market Forecast and CAGR 2020-2025 (Volume)
Fig Melanoma treatment Market Size and CAGR 2015-2019 (Million USD)
Fig Melanoma treatment Market Size and CAGR 2015-2019 (Volume)
Fig Melanoma treatment Market Forecast and CAGR 2020-2025 (Million USD)
Fig Melanoma treatment Market Forecast and CAGR 2020-2025 (Volume)
Fig Bladder cancer treatment Market Size and CAGR 2015-2019 (Million USD)
Fig Bladder cancer treatment Market Size and CAGR 2015-2019 (Volume)
Fig Bladder cancer treatment Market Forecast and CAGR 2020-2025 (Million USD)
Fig Bladder cancer treatment Market Forecast and CAGR 2020-2025 (Volume)
Fig Others Market Size and CAGR 2015-2019 (Million USD)
Fig Others Market Size and CAGR 2015-2019 (Volume)
Fig Others Market Forecast and CAGR 2020-2025 (Million USD)
Fig Others Market Forecast and CAGR 2020-2025 (Volume)
Fig PD-1 inhibitors Market Size and CAGR 2015-2019 (Million USD)
Fig PD-1 inhibitors Market Size and CAGR 2015-2019 (Volume)
Fig PD-1 inhibitors Market Forecast and CAGR 2020-2025 (Million USD)
Fig PD-1 inhibitors Market Forecast and CAGR 2020-2025 (Volume)
Fig PD-L1 inhibitors Market Size and CAGR 2015-2019 (Million USD)
Fig PD-L1 inhibitors Market Size and CAGR 2015-2019 (Volume)
Fig PD-L1 inhibitors Market Forecast and CAGR 2020-2025 (Million USD)
Fig PD-L1 inhibitors Market Forecast and CAGR 2020-2025 (Volume)
Fig CTLA-4 inhibitors Market Size and CAGR 2015-2019 (Million USD)
Fig CTLA-4 inhibitors Market Size and CAGR 2015-2019 (Volume)
Fig CTLA-4 inhibitors Market Forecast and CAGR 2020-2025 (Million USD)
Fig CTLA-4 inhibitors Market Forecast and CAGR 2020-2025 (Volume)
